Human rabies despite post-exposure prophylaxis: a systematic review of fatal breakthrough infections after zoonotic exposures

狂犬病 医学 暴露后预防 免疫抑制 重症监护医学 狂犬病病毒 内科学 病毒学
作者
Erin Whitehouse,Anna Mandra,Jesse Bonwitt,Erin A. Beasley,Joanna Taliano,Agam K. Rao
出处
期刊:Lancet Infectious Diseases [Elsevier]
卷期号:23 (5): e167-e174 被引量:9
标识
DOI:10.1016/s1473-3099(22)00641-7
摘要

Post-exposure prophylaxis (PEP) for rabies is widely administered and highly effective. Nevertheless, sporadic breakthrough infections (ie, rabies in people who have started PEP) have been reported. We conducted a systematic review of articles published between Jan 1, 1980 and June 1, 2022 to characterise breakthrough infections. After reviewing 3380 articles from across all continents, we identified 52 articles, which included a total of 122 breakthrough infections. We classified breakthrough infections on the basis of adherence to core practices (ie, wound cleaning and vaccine administration). Of 86 breakthrough infections with data, median time from exposure to symptom onset was 20 days (IQR 16–24). Most (89 [77%] of 115) participants received PEP within 2 days of an exposure. Severe wounds (defined as those involving multiple wound sites or bites to the head, face, or neck) were common (80 [69%] of 116 [with data]). Deviations from core practices were reported in 68 (56%) of 122 cases. Other possible causes for breakthrough infections included errors in the administration of rabies immunoglobulin, delays in seeking health care, and comorbidities or immunosuppression. Cold-chain integrity assessments and potency testing of PEP biologics were only rarely assessed (8 [7%] of 122 cases), neither of which were found to be a cause of breakthrough infections. Timely and appropriate administration of PEP is crucial to prevent rabies, and although people with high-risk exposures or immunosuppression can develop rabies despite adherence to core practices, this occurrence remains exceedingly rare.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jian94完成签到,获得积分10
2秒前
褚洙完成签到,获得积分10
4秒前
5秒前
FZUer完成签到,获得积分10
5秒前
薛得豪完成签到,获得积分10
7秒前
Jason完成签到 ,获得积分10
7秒前
jocelynhuihui完成签到,获得积分10
7秒前
Siehow完成签到 ,获得积分10
8秒前
tg2024完成签到,获得积分10
8秒前
小杨发布了新的文献求助10
8秒前
8秒前
xiaoyanyan完成签到,获得积分10
10秒前
失眠的之桃完成签到 ,获得积分10
10秒前
肉肉完成签到 ,获得积分10
11秒前
开放平蓝完成签到 ,获得积分20
17秒前
阿强完成签到,获得积分10
20秒前
baibaide完成签到,获得积分10
21秒前
Dlan完成签到,获得积分10
21秒前
开放平蓝关注了科研通微信公众号
22秒前
大反应釜完成签到,获得积分10
25秒前
稳重的蜜蜂完成签到,获得积分10
29秒前
清脆的乌冬面完成签到,获得积分10
29秒前
可夫司机完成签到,获得积分10
31秒前
EdwardKING完成签到,获得积分10
31秒前
silin完成签到,获得积分10
32秒前
time完成签到 ,获得积分10
36秒前
liuxshan完成签到,获得积分10
36秒前
海豚完成签到 ,获得积分10
36秒前
彼方尚有荣光在完成签到 ,获得积分10
40秒前
幸福面包完成签到,获得积分10
40秒前
柚柚粑粑完成签到,获得积分10
41秒前
mengyuhuan完成签到 ,获得积分10
42秒前
白日焰火完成签到 ,获得积分10
42秒前
深情的发夹完成签到,获得积分10
42秒前
Ada完成签到,获得积分10
44秒前
扑火退羽完成签到,获得积分10
45秒前
huahua完成签到 ,获得积分10
45秒前
奮斗完成签到,获得积分10
46秒前
娜na完成签到 ,获得积分10
47秒前
洋洋爱吃枣完成签到 ,获得积分10
48秒前
高分求助中
Manual of Clinical Microbiology, 4 Volume Set (ASM Books) 13th Edition 1000
Cross-Cultural Psychology: Critical Thinking and Contemporary Applications (8th edition) 800
Counseling With Immigrants, Refugees, and Their Families From Social Justice Perspectives pages 800
マンネンタケ科植物由来メロテルペノイド類の網羅的全合成/Collective Synthesis of Meroterpenoids Derived from Ganoderma Family 500
岩石破裂过程的数值模拟研究 500
Electrochemistry 500
[Lambert-Eaton syndrome without calcium channel autoantibodies] 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2374225
求助须知:如何正确求助?哪些是违规求助? 2081558
关于积分的说明 5216569
捐赠科研通 1809196
什么是DOI,文献DOI怎么找? 902933
版权声明 558406
科研通“疑难数据库(出版商)”最低求助积分说明 482119